2010
DOI: 10.1007/s00441-010-1062-9
|View full text |Cite
|
Sign up to set email alerts
|

17β-estradiol reduces expression of MMP-1, -3, and -13 in human primary articular chondrocytes from female patients cultured in a three dimensional alginate system

Abstract: Clinical observations have suggested a relationship between osteoarthritis and a changed sex-hormone metabolism, especially in menopausal women. This study analyzes the effect of 17β-estradiol on expression of matrix metalloproteinases-1, -3, -13 (MMP-1, -3, -13) and tissue inhibitors of metalloproteinases-1, -2 (TIMP-1, -2) in articular chondrocytes. An imbalance of matrix metalloproteinases (MMPs) specialized on degradation of articular cartilage matrix over the respective inhibitors of these enzymes (TIMPs)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
19
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 46 publications
(58 reference statements)
1
19
0
Order By: Relevance
“…c TIMP-1, I, normal group; II, low-selenium group; III, normal + low T-2 group; IV, low selenium + low T-2 group expression of collagen II at the protein and gene levels was significantly reduced in the low Se and T-2 toxin intervention group, with the low-Se diet + high T-2 toxin subgroup showing the most obvious reduction; however, no significant difference was observed between acute (30 days) and chronic (90 days) phases in the various subgroups studied. The results corroborated previous findings [14] demonstrating significantly decreased collagen II expression by human chondrocytes from KBD patients in vitro. The damage to cartilage was generated and lesions occurred for acute poisoning, with 30-day exposure.…”
Section: Discussionsupporting
confidence: 95%
See 1 more Smart Citation
“…c TIMP-1, I, normal group; II, low-selenium group; III, normal + low T-2 group; IV, low selenium + low T-2 group expression of collagen II at the protein and gene levels was significantly reduced in the low Se and T-2 toxin intervention group, with the low-Se diet + high T-2 toxin subgroup showing the most obvious reduction; however, no significant difference was observed between acute (30 days) and chronic (90 days) phases in the various subgroups studied. The results corroborated previous findings [14] demonstrating significantly decreased collagen II expression by human chondrocytes from KBD patients in vitro. The damage to cartilage was generated and lesions occurred for acute poisoning, with 30-day exposure.…”
Section: Discussionsupporting
confidence: 95%
“…MMP-3 cannot directly degrade collagen II; it only degrades collagen II through MMP-1 activation [14]. MMP-13 degrades collagen I, II, III, IV, and X and is the most effective collagen II degrading enzyme, tenfold the activity of MMP-1.…”
Section: Discussionmentioning
confidence: 99%
“…The depth and extent of cartilage damage (A) and the quantification of the damage (B) were determined in hematoxylin-eosin stained, paraffin-embedded knee joint sections from MIA-injected rats (magnifying power synthesis of the cartilage through estrogen receptors (ER-a and ER-b). 38 However, the mechanism of how estradiol impairs MMP expressions remains controversial and has mostly been studied in cell cultures. 34,[38][39][40] The present study found that MIA injection elevated the expression of cytokines such as TNF-a, IL-1b, and IL-6 and the expression of MMP-3 and MMP-13 in the articular cartilage of OVX rats.…”
Section: Yang Et Almentioning
confidence: 99%
“…38 However, the mechanism of how estradiol impairs MMP expressions remains controversial and has mostly been studied in cell cultures. 34,[38][39][40] The present study found that MIA injection elevated the expression of cytokines such as TNF-a, IL-1b, and IL-6 and the expression of MMP-3 and MMP-13 in the articular cartilage of OVX rats. However, although 17b-estradiol treatment modulates the increased expression of MMP-3, MMP-13, and IL-1b, it did not decrease the expression of TNF-a, IL-1b, and IL-6 in the articular cartilage.…”
Section: Yang Et Almentioning
confidence: 99%
“…15,16 Although ERT has been used for many years, recent trials have reported significantly increased risks of breast cancer and other pathologies with this treatment. 17 Many studies are being performed to discover effective and nontoxic materials with estrogen-like activity to replace estrogen in therapies for postmenopausal women.…”
Section: Introduction Smentioning
confidence: 99%